Glenview, IL, United States of America

Larry G Birkenmeyer

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 5.4

ph-index = 5

Forward Citations = 417(Granted Patents)


Location History:

  • Chicago, IL (US) (1995 - 2002)
  • Glenview, IL (US) (2011 - 2022)

Company Filing History:


Years Active: 1995-2022

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Unveiling Larry G Birkenmeyer: An Innovator in Glenview, IL

Introduction:

Larry G Birkenmeyer is a distinguished inventor hailing from Glenview, IL, with a remarkable portfolio of 18 patents to his name. His groundbreaking work in the field of biotechnology has left a lasting impact on the industry.

Latest Patents:

Among his latest patents is the invention of Anti-GP73 monoclonal antibodies and methods of obtaining the same. These antibodies revolutionize the detection of Golgi protein 73 (GP73) and fucosylated GP73 in samples, showcasing Birkenmeyer's commitment to advancing diagnostic technologies.

Career Highlights:

Larry G Birkenmeyer has made significant contributions to the field while working at renowned companies such as Abbott Laboratories and AbbVie Deutschland GmbH & Co. KG. His innovative spirit and dedication to research have been pivotal in driving forward advancements in the biotech sector.

Collaborations:

Throughout his career, Birkenmeyer has collaborated with exceptional professionals in the industry, including Suresh M Desai and Anthony Scott Muerhoff. Together, they have worked on cutting-edge projects that have pushed the boundaries of scientific innovation.

Conclusion:

In conclusion, Larry G Birkenmeyer stands as a trailblazer in the realm of biotechnology, with a rich tapestry of patents highlighting his ingenuity and expertise. His relentless pursuit of excellence continues to inspire future generations of inventors and researchers in the pursuit of innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…